Vaccine for corporate travel


The recovery of business travel was likely to stall in the fourth quarter, according to a note from UBS.

The comments came as hotel groups continued to expand their corporate offering away from traditional business travel and towards working from hotels and corporate subscriptions.

UBS analyst Robyn Farley said: “We continue to highlight risk that lodging momentum (sequential improvement) may stall in Q4, as leisure makes up a smaller percentage of mix and hotels are more reliant on business

Nothing like a good cliffhanger… care to see how the story ends?

Register with your activation code to access this story.